Ginkgo Bioworks Expands Genomics Capabilities with Volta Labs Integration

Court: N.D. California

Case: 4:21-cv-08943

Ginkgo Bioworks DNA integrated Volta Labs' Callisto™ Sample Prep System into its Illumina sequencing workflow to streamline genomics research. The system improves short-read sequencing efficiency, cuts costs, and expands access to multiple technologies. Ginkgo advances biosecurity and cell programming across markets, with earnings due February 28, 2025.Meanwhile, Ginkgo Bioworks has agreed to a $17.75 million settlement with DNA investors to resolve claims related to the Scorpion Capital report and reliance on related parties for revenue. You can check more information about it here and file for a payout.

Ginkgo Bioworks DNA integrated Volta Labs' Callisto™ Sample Prep System into its Illumina sequencing workflow to streamline genomics research. The system improves short-read sequencing efficiency, cuts costs, and expands access to multiple technologies. Ginkgo advances biosecurity and cell programming across markets, with earnings due February 28, 2025.

Meanwhile, Ginkgo Bioworks has agreed to a $17.75 million settlement with DNA investors to resolve claims related to the Scorpion Capital report and reliance on related parties for revenue. You can check more information about it here and file for a payout.